AM

Alpesh Mohanbhai Mungara

Active Director Director DIN 11118459
DIN 11118459 First appointment May 2025 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Alpesh Mohanbhai Mungara

Data last updated:

Alpesh Mohanbhai Mungara is a Director at Cyent Lifescience Private Limited (since 2025). The company operates in Healthcare.

DIN 11118459
Primary Designation Director
Industry Healthcare
First Appointment 21 May 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Cyent Lifescience Private Limited U21002GJ2025PTC163246
Director21 May 20252025Active

Board colleagues of Alpesh Mohanbhai Mungara

NameDINCompanyDesignation
Himalay Dineshbhai Giniya07523010Cyent Lifescience Private LimitedDirector

Directorship timeline

Open interactive timeline →
Cyent Lifescience Private Limited
Premium access

Shareholding and investment profile for Alpesh Mohanbhai Mungara

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Alpesh Mohanbhai Mungara

Alpesh Mohanbhai Mungara currently holds 1 directorship: Cyent Lifescience Private Limited (Director, since 21 May 2025).

Alpesh Mohanbhai Mungara was first appointed on 21 May 2025 as Director at Cyent Lifescience Private Limited.

The current boards of Alpesh Mohanbhai Mungara's companies include Himalay Dineshbhai Giniya (Cyent Lifescience Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available